These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15485599

  • 21. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 22. Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve.
    Strauer BE, Schwartzkopff B.
    Am J Hypertens; 1998 Jul; 11(7):879-81. PubMed ID: 9683053
    [Abstract] [Full Text] [Related]

  • 23. Clinical trials of single-drug therapy for the cardiac effects of hypertension.
    Gottdiener JS.
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):12S-18S. PubMed ID: 10077415
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of the effect of antihypertensive drugs on left ventricular hypertrophy regression].
    Koziolova NA, Shatunova IM.
    Kardiologiia; 2014 Jan; 54(3):82-91. PubMed ID: 25102754
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M.
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [Abstract] [Full Text] [Related]

  • 30. Clinical methods for the detection and management of left ventricular hypertrophy.
    Swamy RS, Lang RM.
    Indian Heart J; 2010 Sep; 62(5):384-7. PubMed ID: 23189877
    [Abstract] [Full Text] [Related]

  • 31. [Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].
    Anguita Sánchez M.
    Rev Esp Cardiol; 1999 Sep; 52 Suppl 3():34-8. PubMed ID: 10614147
    [Abstract] [Full Text] [Related]

  • 32. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 33. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB.
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [Abstract] [Full Text] [Related]

  • 34. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlöf B, de Simone G, Devereux RB.
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.
    Izzo JL, Gradman AH.
    Med Clin North Am; 2004 Sep; 88(5):1257-71. PubMed ID: 15331316
    [Abstract] [Full Text] [Related]

  • 36. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R, Irace L, Perna B, Caruso C, Guida M, Iacono A.
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD, Lapenna D, Cuccurullo F.
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [Abstract] [Full Text] [Related]

  • 39. Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update.
    Milan A, Caserta MA, Avenatti E, Abram S, Veglio F.
    Intern Emerg Med; 2010 Dec; 5(6):469-79. PubMed ID: 20480263
    [Abstract] [Full Text] [Related]

  • 40. [The effect of antihypertensive therapy on left ventricular mass and diastolic filling in light and moderate hypertension].
    Salcedo A, Lekuona I, Laraudogoitia E, Echevarría P, Madariaga JA, Palomar S, Zumalde J, Barrenetxea JI.
    Med Clin (Barc); 1993 May 01; 100(17):646-50. PubMed ID: 8497169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.